Beijing Baicare Closes $9 Million Round for Clinical Diagnostic Devices

01:18 EDT 16 Aug 2019 | ChinaBio Today

Beijing Baicare Biotech closed a $9 million B financing that was led by Sinopharm Capital and included the company's existing shareholders. Formed in 2013, Baicare makes automated nucleic acid detection devices for clinical use using microfluidic chips and gene detection technology. The company offers a program to detect pathogenic bacteria and another to assess antibiotic/drug resistance that guides doctors toward more effective treatments. Because of its stature, Sinopharm will be able to help Baicare increase its visibility in the clinical diagnostic field. More details....

Share this with colleagues:

Original Article: Beijing Baicare Closes $9 Million Round for Clinical Diagnostic Devices


More From BioPortfolio on "Beijing Baicare Closes $9 Million Round for Clinical Diagnostic Devices"

Quick Search

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...